SEP 11, 2017 5:38 PM PDT

Fire Ant Venom: The Next Ingredient in Skin Care Products?

WRITTEN BY: Kara Marker

A unique quality of the main toxic “ingredient” in fire ant venom makes it the newest, if unlikely, candidate for treating an autoimmune skin disorder, psoriasis. The most recent study has only finished trials in mouse models of the disease, but if clinical trials in humans are also successful - and safe - fire ant venom could be the solution a lot of psoriasis patients have been looking for.

 

Fire ants (Solenopsis invicta) on the hill-top of West Trail, Lost Maples State Natural Area, Texas. Credit: Wing-Chi Poon

About psoriasis

This skin condition is not contagious, but scientists don’t know much about what causes it other than that genetic and environmental factors are involved somehow. A person with psoriasis experiences lesions on the skin that develop due to skin cells growing exponentially faster than they should. Current treatments for psoriasis mostly include topical steroids, an approach that has known side effects such as skin thinning and easy bruising.

About the venom

Solenopsins from fire ant venom have been subjects of study before. Lead author of the present study, Jack Arbiser, MD, PhD, found in 2007 that these compounds have anti-blood vessel growth properties, making them a potential anticancer agent - tumors need a blood supply for oxygen and nutrients just like healthy human organs do.

Just like a common ingredient in skin care products, molecules called ceramides, solenopsins influence the barrier function of the skin. However, unlike solenopsins, ceramides are capable of degradation into an inflammatory molecule, sphingosine-1-phosphate (S1P), an inflammatory molecule.

Arbiser and his team studied two types of solenopsins that look and act like ceramides without the negative effect of being transformed into S1P. They used a mouse model of psoriasis, treated with skin cream with one percent solenopsins for 28 days.

Compared to controls, the mice who received cream with solenopsin experienced a decrease in skin thickness, lower infiltration of immune cells to the skin, suppressed production of inflammatory signal IL-22 and increased production of anti-inflammatory IL-12. After observing gene activity patterns, researchers also saw decreased activity of genes that are usually activated by steroid and ultraviolet light treatments for psoriasis.

"This may be compensatory and a mechanism of resistance to anti-psoriasis therapy, and it suggests that the solenopsin compounds could be used in combination with existing approaches," Arbiser explained. "We believe that solenopsin analogs are contributing to full restoration of the barrier function in the skin. Emollients can soothe the skin in psoriasis, but they are not sufficient for restoration of the barrier."

Emollients are a type of moisturizer that relieves itchiness and discomfort in the skin. With continued study of solenopsin as the active ingredient of a new line of psoriasis treatments, people with psoriasis could soon have a new option for therapeutic intervention.

The present study was published in the journal Scientific Reports.

Sources: National Eczema Society, National Psoriasis Foundation, Emory Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 12, 2020
Immunology
Is Gluten Becoming More Immunoreactive?
AUG 12, 2020
Is Gluten Becoming More Immunoreactive?
In recent years, the number of people diagnosed with celiac disease has increased drastically, even with many undiagnose ...
SEP 21, 2020
Cell & Molecular Biology
The Hormones We Have at Birth Are Linked to Disease Throughout Life
SEP 21, 2020
The Hormones We Have at Birth Are Linked to Disease Throughout Life
New work may help explain why some autoimmune or immune-related diseases are more common in women, who are more likely t ...
OCT 06, 2020
Immunology
COVID Triggers Abnormalities in Immune Monocytes
OCT 06, 2020
COVID Triggers Abnormalities in Immune Monocytes
University of Manchester immunologists are the first to make an interesting observation about the white blood cells of p ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
Loading Comments...